SOHO Highlights: State of the Art and Next Questions
Avatar

SOHO Highlights - State of the Art & Next Questions: T-Cell Lymphomas

By SOHO Highlights: State of the Art and Next Questions FEATURING Barbara Pro
By SOHO Highlights: State of the Art and Next Questions FEATURING Barbara Pro
38 views
December 7, 2022
SOHO members and Highlights meeting attendees now have access to the presentations on-demand, as well ...
read more ↘
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Related Content

AUTOPLAY
23:03
MyCancerHaven

Basics of T-Cell Lymphoma: Diagnosis and Treatment

Feat. R. Vij, N. Mehta-Shah
19:38
19th Annual International Ultmann Chicago Lymphoma Symposium

T-Cell Lymphomas: Impact of Classification on Treatment

Feat. N. Mehta-Shah
21:53
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

Therapeutic Advances in T-Cell Lymphomas

Feat. S. Barta
11:01
i3 Health

Diagnosis and Evidence-Based Management of T-Cell Lymphoma

Feat. A. Goodman
34:28
Indy Hematology Review

Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas

Feat. T. Phillips
10:50
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: T-Cell Lymphoma

Feat. M. Lunning
18:10
SOHO Brazil 2023

2023 SOHO® Brazil: "Moving Beyond CHOP/CHOEP - How Disease Feat…

Feat. A. Moskowitz
19:32
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Tailoring Therapy for PTCL

Feat. J. Zain
16:27
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Therapeutic Advances in T-Cell Lymphoma in 2024

Feat. S. Barta
18:39
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Managing Rare T-Cell Lymphoma Subtypes

Feat. B. Pro
38:56
SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: T-Cell Lymphoma

Feat. M. Lunning
12:55
Yale Cancer Center

ASH 2022 Highlights: T-Cell Lymphoma and Hodgkin Lymphoma

Feat. T. Sethi
18:54
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: New Insights Into the Pathogenesis of T-Cell Lymphoma and…

Feat. L. de Leval
26:12
Indy Hematology Review

What We Recommend for Aggressive B- and T-Cell Lymphomas in 2022

Feat. J. Leonard
27:47
Indy Hematology Review

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Feat. S. Smith
10:55
PrecisCa

Heme Tumor Board: 60 y/o Female Presents With Newly Diagnosed CD30- …

Feat. D. Pollyea, T. Fraum, M. Thirman, M. Kamdar
27:51
Indy Hematology Review

Standard Management of Aggressive Lymphomas and Data on Emerging The…

Feat. J. Leonard
03:10
PrecisCa

What Is Hepatosplenic T-Cell Lymphoma and How Do You Treat It?

Feat. J. Abramson
23:26
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Harnessing the Immune System in Patients With Lymphoma

Feat. S. Ansell
30:40
[PRIVATE] 2022 AAD Annual Meeting Coverage

Melanoma: New Therapies in Advanced Stage III and Stage IV

Feat. B. Dreno